View Financial HealthS Crypto Energy 配当と自社株買い配当金 基準チェック /06S Crypto Energy配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • May 15S Crypto Energy Inc., Annual General Meeting, Jun 29, 2026S Crypto Energy Inc., Annual General Meeting, Jun 29, 2026.New Risk • May 15New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: JP¥14.2b (US$89.6m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Share price has been highly volatile over the past 3 months (14% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Shareholders have been diluted in the past year (24% increase in shares outstanding). Market cap is less than US$100m (JP¥14.2b market cap, or US$89.6m).お知らせ • May 09S Crypto Energy Inc. to Report Fiscal Year 2026 Results on May 14, 2026S Crypto Energy Inc. announced that they will report fiscal year 2026 results on May 14, 2026New Risk • Apr 06New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: JP¥15.4b (US$96.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Share price has been highly volatile over the past 3 months (14% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Shareholders have been diluted in the past year (24% increase in shares outstanding). Market cap is less than US$100m (JP¥15.4b market cap, or US$96.7m).New Risk • Jan 03New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 24% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Share price has been highly volatile over the past 3 months (21% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (4.4% net profit margin). Shareholders have been diluted in the past year (24% increase in shares outstanding).お知らせ • Dec 16S Science Company, Ltd. to Report Q3, 2026 Results on Feb 13, 2026S Science Company, Ltd. announced that they will report Q3, 2026 results on Feb 13, 2026New Risk • Nov 15New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended September 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Share price has been highly volatile over the past 3 months (24% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risk Profit margins are more than 30% lower than last year (4.4% net profit margin).お知らせ • Sep 27S Science Company, Ltd. to Report Q2, 2026 Results on Nov 14, 2025S Science Company, Ltd. announced that they will report Q2, 2026 results on Nov 14, 2025お知らせ • Aug 20S Science Company, Ltd. announced that it expects to receive ¥40.842 million in funding from Long Corridor Asset Management Limited, Lighthouse Investment Partners, LLC, Blackstone Alternative Asset Management L.P., Kay Leo Brothers Limited and another investorS Science Company, Ltd. announced a private placement to issue 334,500 series 8 stock acquisition rights at an issue price of ¥72 for gross proceeds of ¥24,084,000 and 220,500 series 9 stock acquisition rights at an issue price of ¥76 for gross proceeds of ¥16,758,000 for aggregate proceeds of ¥40,842,000 on August 18, 2025. The transaction includes participation from new investor, Long Corridor Alpha Opportunities Master Fund, a fund managed by Long Corridor Asset Management Limited for 234,150 stock acquisition rights, LMA SPC - MAP 246 Segregated Portfolio, a fund managed by Lighthouse Investment Partners, LLC for 33,450 stock acquisition rights, Bemap Master Fund Ltd., a fund managed by Blackstone Alternative Asset Management L.P. for 66,900 stock acquisition rights in series 8 stock acquisition rights offering and from Kay Leo Brothers Limited for 175,000 stock acquisition rights and Yuta Misaki for 45,500 stock acquisition rights in series 9 stock acquisition rights offering. The potential shares from issuance of series 8 stock acquisition rights will be 33,450,000 and from issuance of series 9 stock acquisition rights will be 22,050,000. The initial exercise price of stock acquisition right will be ¥122 for an exercise period from September 5, 2025 to September 4, 2028. The transaction will happen through third party allocation. The issue date will be September 4, 2025. The transaction has been approved at board of director meeting of the company.お知らせ • Jun 20S Science Company, Ltd. to Report Q1, 2026 Results on Aug 14, 2025S Science Company, Ltd. announced that they will report Q1, 2026 results on Aug 14, 2025New Risk • Jun 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (37% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Profit margins are more than 30% lower than last year (4.4% net profit margin). Market cap is less than US$100m (JP¥11.0b market cap, or US$76.9m).お知らせ • May 15S Science Company, Ltd., Annual General Meeting, Jun 27, 2025S Science Company, Ltd., Annual General Meeting, Jun 27, 2025.お知らせ • Mar 25S Science Company, Ltd. to Report Fiscal Year 2025 Results on May 14, 2025S Science Company, Ltd. announced that they will report fiscal year 2025 results on May 14, 2025New Risk • Mar 18New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.5% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (4.4% net profit margin). Market cap is less than US$100m (JP¥4.25b market cap, or US$28.5m).Valuation Update With 7 Day Price Move • Mar 13Investor sentiment improves as stock rises 17%After last week's 17% share price gain to JP¥28.00, the stock trades at a trailing P/E ratio of 72.1x. Average trailing P/E is 11x in the Metals and Mining industry in Japan. Total loss to shareholders of 24% over the past three years.お知らせ • Dec 20S Science Company, Ltd. to Report Q3, 2025 Results on Feb 13, 2025S Science Company, Ltd. announced that they will report Q3, 2025 results on Feb 13, 2025New Risk • Nov 21New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 42% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.9% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (4.4% net profit margin). Market cap is less than US$100m (JP¥3.12b market cap, or US$20.2m).お知らせ • Sep 21S Science Company, Ltd. to Report Q2, 2025 Results on Nov 13, 2024S Science Company, Ltd. announced that they will report Q2, 2025 results on Nov 13, 2024分析記事 • Aug 03S Science Company, Ltd.'s (TSE:5721) 29% Jump Shows Its Popularity With InvestorsS Science Company, Ltd. ( TSE:5721 ) shares have had a really impressive month, gaining 29% after a shaky period...Valuation Update With 7 Day Price Move • Jul 31Investor sentiment improves as stock rises 17%After last week's 17% share price gain to JP¥27.00, the stock trades at a trailing P/E ratio of 9x. Average trailing P/E is 10x in the Metals and Mining industry in Japan. Total loss to shareholders of 29% over the past three years.Valuation Update With 7 Day Price Move • Jul 05Investor sentiment improves as stock rises 23%After last week's 23% share price gain to JP¥27.00, the stock trades at a trailing P/E ratio of 9x. Average trailing P/E is 11x in the Metals and Mining industry in Japan. Total loss to shareholders of 27% over the past three years.お知らせ • Jun 22S Science Company, Ltd. to Report Q1, 2025 Results on Aug 13, 2024S Science Company, Ltd. announced that they will report Q1, 2025 results on Aug 13, 2024お知らせ • May 31Life Intelligent Enterprise Holdings Co.,Ltd. (TSE:5856) agreed to acquire Nagomi Sekkei Co., Ltd. from S Science Company, Ltd. (TSE:5721).Life Intelligent Enterprise Holdings Co.,Ltd. (TSE:5856) agreed to acquire Nagomi Sekkei Co., Ltd. from S Science Company, Ltd. (TSE:5721) on May 30, 2024. As part of the transaction, Life Intelligent will acquire 3,021 shares of Nagomi Sekkei. The parties are scheduled to enter into an agreement on July 1, 2024 or later after approval at the Shareholders Meeting. The transaction is conditional upon shareholder approval of S Science. The transaction is expected to close on July 1, 2024 or later after approval at the Shareholders Meeting.分析記事 • May 21Shareholders Shouldn’t Be Too Comfortable With S Science Company's (TSE:5721) Strong EarningsEven though S Science Company, Ltd. ( TSE:5721 ) posted strong earnings recently, the stock hasn't reacted in a large...Reported Earnings • May 17Full year 2024 earnings released: EPS: JP¥3.01 (vs JP¥0.74 loss in FY 2023)Full year 2024 results: EPS: JP¥3.01 (up from JP¥0.74 loss in FY 2023). Revenue: JP¥1.54b (up 14% from FY 2023). Net income: JP¥426.0m (up JP¥531.0m from FY 2023). Profit margin: 28% (up from net loss in FY 2023). Over the last 3 years on average, earnings per share has increased by 99% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.お知らせ • May 16S Science Company, Ltd., Annual General Meeting, Jun 27, 2024S Science Company, Ltd., Annual General Meeting, Jun 27, 2024.分析記事 • Mar 05S Science Company, Ltd.'s (TSE:5721) Share Price Matching Investor OpinionWhen you see that almost half of the companies in the Metals and Mining industry in Japan have price-to-sales ratios...Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improves as stock rises 18%After last week's 18% share price gain to JP¥26.00, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 9x in the Metals and Mining industry in Japan. Total loss to shareholders of 40% over the past three years.お知らせ • Mar 02S Science Company, Ltd. to Report Fiscal Year 2024 Results on May 13, 2024S Science Company, Ltd. announced that they will report fiscal year 2024 results on May 13, 2024Reported Earnings • Feb 15Third quarter 2024 earnings released: EPS: JP¥1.04 (vs JP¥0.21 loss in 3Q 2023)Third quarter 2024 results: EPS: JP¥1.04 (up from JP¥0.21 loss in 3Q 2023). Revenue: JP¥339.0m (up 12% from 3Q 2023). Net income: JP¥147.0m (up JP¥177.0m from 3Q 2023). Profit margin: 43% (up from net loss in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings.お知らせ • Dec 16S Science Company, Ltd. to Report Q3, 2024 Results on Feb 13, 2024S Science Company, Ltd. announced that they will report Q3, 2024 results on Feb 13, 2024New Risk • Nov 16New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 38% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (38% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Market cap is less than US$100m (JP¥3.12b market cap, or US$20.6m).Reported Earnings • Nov 12Second quarter 2024 earnings released: EPS: JP¥1.17 (vs JP¥0.064 loss in 2Q 2023)Second quarter 2024 results: EPS: JP¥1.17 (up from JP¥0.064 loss in 2Q 2023). Revenue: JP¥490.0m (up 54% from 2Q 2023). Net income: JP¥166.0m (up JP¥175.0m from 2Q 2023). Profit margin: 34% (up from net loss in 2Q 2023).お知らせ • Sep 21S Science Company, Ltd. to Report Q2, 2024 Results on Nov 10, 2023S Science Company, Ltd. announced that they will report Q2, 2024 results on Nov 10, 2023Reported Earnings • Aug 12First quarter 2024 earnings released: EPS: JP¥1.50 (vs JP¥0.22 loss in 1Q 2023)First quarter 2024 results: EPS: JP¥1.50 (up from JP¥0.22 loss in 1Q 2023). Revenue: JP¥446.0m (up 31% from 1Q 2023). Net income: JP¥213.0m (up JP¥244.0m from 1Q 2023). Profit margin: 48% (up from net loss in 1Q 2023).お知らせ • Jun 22S Science Company, Ltd. to Report Q1, 2024 Results on Aug 10, 2023S Science Company, Ltd. announced that they will report Q1, 2024 results on Aug 10, 2023Reported Earnings • May 16Full year 2023 earnings released: JP¥0.74 loss per share (vs JP¥2.74 loss in FY 2022)Full year 2023 results: JP¥0.74 loss per share (improved from JP¥2.74 loss in FY 2022). Revenue: JP¥1.36b (up 18% from FY 2022). Net loss: JP¥105.0m (loss narrowed 68% from FY 2022).お知らせ • May 14S Science Company, Ltd., Annual General Meeting, Jun 29, 2023S Science Company, Ltd., Annual General Meeting, Jun 29, 2023.Reported Earnings • Feb 15Third quarter 2023 earnings released: JP¥0.21 loss per share (vs JP¥0.73 loss in 3Q 2022)Third quarter 2023 results: JP¥0.21 loss per share (improved from JP¥0.73 loss in 3Q 2022). Revenue: JP¥304.0m (up 1.3% from 3Q 2022). Net loss: JP¥30.0m (loss narrowed 68% from 3Q 2022).お知らせ • Dec 27S Science Company, Ltd. to Report Q3, 2023 Results on Feb 13, 2023S Science Company, Ltd. announced that they will report Q3, 2023 results on Feb 13, 2023Reported Earnings • Nov 16Second quarter 2023 earnings released: JP¥0.064 loss per share (vs JP¥0.39 loss in 2Q 2022)Second quarter 2023 results: JP¥0.064 loss per share (improved from JP¥0.39 loss in 2Q 2022). Revenue: JP¥319.0m (up 28% from 2Q 2022). Net loss: JP¥9.00m (loss narrowed 79% from 2Q 2022).Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Outside Independent Director Seiji Arikawa was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 13Second quarter 2023 earnings released: JP¥0.064 loss per share (vs JP¥0.39 loss in 2Q 2022)Second quarter 2023 results: JP¥0.064 loss per share (improved from JP¥0.39 loss in 2Q 2022). Revenue: JP¥319.0m (up 28% from 2Q 2022). Net loss: JP¥9.00m (loss narrowed 79% from 2Q 2022).お知らせ • Sep 17S Science Company, Ltd. to Report Q2, 2023 Results on Nov 10, 2022S Science Company, Ltd. announced that they will report Q2, 2023 results on Nov 10, 2022Reported Earnings • Aug 12First quarter 2023 earnings released: JP¥0.22 loss per share (vs JP¥0.77 loss in 1Q 2022)First quarter 2023 results: JP¥0.22 loss per share (up from JP¥0.77 loss in 1Q 2022). Revenue: JP¥340.0m (up 69% from 1Q 2022). Net loss: JP¥31.0m (loss narrowed 62% from 1Q 2022).お知らせ • Jun 10S Science Company, Ltd. to Report Q1, 2023 Results on Aug 10, 2022S Science Company, Ltd. announced that they will report Q1, 2023 results on Aug 10, 2022Reported Earnings • May 16Full year 2022 earnings released: JP¥2.74 loss per share (vs JP¥2.67 loss in FY 2021)Full year 2022 results: JP¥2.74 loss per share (down from JP¥2.67 loss in FY 2021). Revenue: JP¥1.16b (up 6.8% from FY 2021). Net loss: JP¥329.0m (loss widened 22% from FY 2021).お知らせ • May 14S Science Company, Ltd., Annual General Meeting, Jun 29, 2022S Science Company, Ltd., Annual General Meeting, Jun 29, 2022.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Outside Independent Director Seiji Arikawa was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 08S Science Company, Ltd. to Report Fiscal Year 2022 Results on May 12, 2022S Science Company, Ltd. announced that they will report fiscal year 2022 results on May 12, 2022Reported Earnings • Feb 10Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: JP¥0.73 loss per share (up from JP¥1.12 loss in 3Q 2021). Revenue: JP¥300.0m (up 26% from 3Q 2021). Net loss: JP¥93.0m (loss narrowed 18% from 3Q 2021). Revenue was in line with analyst estimates.お知らせ • Nov 30S Science Company, Ltd. announced that it has received ¥480 million in funding from LIH Co., Ltd.On November 29, 2021, S Science Company, Ltd closed the transaction.Reported Earnings • Nov 12Second quarter 2022 earnings released: JP¥0.39 loss per share (vs JP¥1.12 loss in 2Q 2021)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2022 results: Revenue: JP¥250.0m (up 5.0% from 2Q 2021). Net loss: JP¥43.0m (loss narrowed 62% from 2Q 2021).お知らせ • Mar 13S Science Company, Ltd. to Report Fiscal Year 2021 Results on May 14, 2021S Science Company, Ltd. announced that they will report fiscal year 2021 results on May 14, 2021お知らせ • Mar 07S Science Company, Ltd. announced that it expects to receive ¥2.75 million in funding from Evolution Capital Management, LLCS Science Co. Ltd. (TSE:5721) announced a third-party allotment agreement for a private placement of 250,000 units of the 6th Stock Acquisition Rights at an issue price of ¥11 per stock acquisition right for gross proceeds of ¥2,750,000 on March 5, 2021. The transaction will involve participation from Evo Fund, a fund managed by Evolution Capital Management, LLC. The stock acquisition right may be converted into 25,000,000 shares (100 shares per stock acquisition right), with initial exercise price of the amount equivalent to 90% of the condition determination standard stock price rounded up to the nearest ¥0.1., and no maximum exercise price. The company will raise ¥1,074,750,000 on exercise of security. The company will pay issuance expenses of ¥8,000,000 and will receive net proceeds on ¥1,074,750,000 on exercise of security. The period during which the stock acquisition rights can be exercised from March 30, 2021 to April 26, 2022. The allotment date is March 29, 2021. The transaction is approved by the board of directors of the company.Is New 90 Day High Low • Jan 12New 90-day low: JP¥37.00The company is down 20% from its price of JP¥46.00 on 14 October 2020. The Japanese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Metals and Mining industry, which is up 27% over the same period.お知らせ • Dec 30S Science Company, Ltd. to Report Q3, 2021 Results on Feb 12, 2021S Science Company, Ltd. announced that they will report Q3, 2021 results on Feb 12, 2021Is New 90 Day High Low • Dec 22New 90-day low: JP¥38.00The company is down 17% from its price of JP¥46.00 on 23 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Metals and Mining industry, which is up 16% over the same period.Is New 90 Day High Low • Dec 02New 90-day low: JP¥43.00The company is down 4.0% from its price of JP¥45.00 on 03 September 2020. The Japanese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Metals and Mining industry, which is up 10.0% over the same period.お知らせ • Aug 15S Science Company, Ltd. (TSE:5721) completed the acquisition of Nagomi Sekkei Co., Ltd. from Yasuhiro Fukumura, Kyoko Fukumura, Wakabayashi Tetsuchun, Morita Shinada and others.S Science Company, Ltd. (TSE:5721) concluded a transfer agreement to acquire Nagomi Sekkei Co., Ltd. from Yasuhiro Fukumura, Kyoko Fukumura, Wakabayashi Tetsuchun, Morita Shinada and others for approximately ¥120 million on March 26, 2020. Post completion, Nagomi Sekkei will become wholly owned subsidiary of S Science Company. For the year ended March 31, 2019, Nagomi Sekkei had sales of ¥724 million, operating loss of ¥7 million, net loss of ¥1 million, net assets of ¥19 million and total assets of ¥193 million. Transaction was resolved by the Board of S Science Company. Transaction is expected to close on April 1, 2020. S Science Company, Ltd. (TSE:5721) completed the acquisition of Nagomi Sekkei Co., Ltd. from Yasuhiro Fukumura, Kyoko Fukumura, Wakabayashi Tetsuchun, Morita Shinada and others on April 1, 2020.決済の安定と成長配当データの取得安定した配当: 5721の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: 5721の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場S Crypto Energy 配当利回り対市場5721 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (5721)n/a市場下位25% (JP)1.8%市場トップ25% (JP)3.9%業界平均 (Metals and Mining)2.7%アナリスト予想 (5721) (最長3年)n/a注目すべき配当: 5721は最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: 5721は最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: 5721の 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: 5721が配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YJP 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/10 13:58終値2026/06/10 00:00収益2024/09/30年間収益2024/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋S Crypto Energy Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 15S Crypto Energy Inc., Annual General Meeting, Jun 29, 2026S Crypto Energy Inc., Annual General Meeting, Jun 29, 2026.
New Risk • May 15New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: JP¥14.2b (US$89.6m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Share price has been highly volatile over the past 3 months (14% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Shareholders have been diluted in the past year (24% increase in shares outstanding). Market cap is less than US$100m (JP¥14.2b market cap, or US$89.6m).
お知らせ • May 09S Crypto Energy Inc. to Report Fiscal Year 2026 Results on May 14, 2026S Crypto Energy Inc. announced that they will report fiscal year 2026 results on May 14, 2026
New Risk • Apr 06New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: JP¥15.4b (US$96.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Share price has been highly volatile over the past 3 months (14% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Shareholders have been diluted in the past year (24% increase in shares outstanding). Market cap is less than US$100m (JP¥15.4b market cap, or US$96.7m).
New Risk • Jan 03New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 24% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Share price has been highly volatile over the past 3 months (21% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (4.4% net profit margin). Shareholders have been diluted in the past year (24% increase in shares outstanding).
お知らせ • Dec 16S Science Company, Ltd. to Report Q3, 2026 Results on Feb 13, 2026S Science Company, Ltd. announced that they will report Q3, 2026 results on Feb 13, 2026
New Risk • Nov 15New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended September 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Share price has been highly volatile over the past 3 months (24% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risk Profit margins are more than 30% lower than last year (4.4% net profit margin).
お知らせ • Sep 27S Science Company, Ltd. to Report Q2, 2026 Results on Nov 14, 2025S Science Company, Ltd. announced that they will report Q2, 2026 results on Nov 14, 2025
お知らせ • Aug 20S Science Company, Ltd. announced that it expects to receive ¥40.842 million in funding from Long Corridor Asset Management Limited, Lighthouse Investment Partners, LLC, Blackstone Alternative Asset Management L.P., Kay Leo Brothers Limited and another investorS Science Company, Ltd. announced a private placement to issue 334,500 series 8 stock acquisition rights at an issue price of ¥72 for gross proceeds of ¥24,084,000 and 220,500 series 9 stock acquisition rights at an issue price of ¥76 for gross proceeds of ¥16,758,000 for aggregate proceeds of ¥40,842,000 on August 18, 2025. The transaction includes participation from new investor, Long Corridor Alpha Opportunities Master Fund, a fund managed by Long Corridor Asset Management Limited for 234,150 stock acquisition rights, LMA SPC - MAP 246 Segregated Portfolio, a fund managed by Lighthouse Investment Partners, LLC for 33,450 stock acquisition rights, Bemap Master Fund Ltd., a fund managed by Blackstone Alternative Asset Management L.P. for 66,900 stock acquisition rights in series 8 stock acquisition rights offering and from Kay Leo Brothers Limited for 175,000 stock acquisition rights and Yuta Misaki for 45,500 stock acquisition rights in series 9 stock acquisition rights offering. The potential shares from issuance of series 8 stock acquisition rights will be 33,450,000 and from issuance of series 9 stock acquisition rights will be 22,050,000. The initial exercise price of stock acquisition right will be ¥122 for an exercise period from September 5, 2025 to September 4, 2028. The transaction will happen through third party allocation. The issue date will be September 4, 2025. The transaction has been approved at board of director meeting of the company.
お知らせ • Jun 20S Science Company, Ltd. to Report Q1, 2026 Results on Aug 14, 2025S Science Company, Ltd. announced that they will report Q1, 2026 results on Aug 14, 2025
New Risk • Jun 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (37% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Profit margins are more than 30% lower than last year (4.4% net profit margin). Market cap is less than US$100m (JP¥11.0b market cap, or US$76.9m).
お知らせ • May 15S Science Company, Ltd., Annual General Meeting, Jun 27, 2025S Science Company, Ltd., Annual General Meeting, Jun 27, 2025.
お知らせ • Mar 25S Science Company, Ltd. to Report Fiscal Year 2025 Results on May 14, 2025S Science Company, Ltd. announced that they will report fiscal year 2025 results on May 14, 2025
New Risk • Mar 18New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.5% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (4.4% net profit margin). Market cap is less than US$100m (JP¥4.25b market cap, or US$28.5m).
Valuation Update With 7 Day Price Move • Mar 13Investor sentiment improves as stock rises 17%After last week's 17% share price gain to JP¥28.00, the stock trades at a trailing P/E ratio of 72.1x. Average trailing P/E is 11x in the Metals and Mining industry in Japan. Total loss to shareholders of 24% over the past three years.
お知らせ • Dec 20S Science Company, Ltd. to Report Q3, 2025 Results on Feb 13, 2025S Science Company, Ltd. announced that they will report Q3, 2025 results on Feb 13, 2025
New Risk • Nov 21New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 42% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.9% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (4.4% net profit margin). Market cap is less than US$100m (JP¥3.12b market cap, or US$20.2m).
お知らせ • Sep 21S Science Company, Ltd. to Report Q2, 2025 Results on Nov 13, 2024S Science Company, Ltd. announced that they will report Q2, 2025 results on Nov 13, 2024
分析記事 • Aug 03S Science Company, Ltd.'s (TSE:5721) 29% Jump Shows Its Popularity With InvestorsS Science Company, Ltd. ( TSE:5721 ) shares have had a really impressive month, gaining 29% after a shaky period...
Valuation Update With 7 Day Price Move • Jul 31Investor sentiment improves as stock rises 17%After last week's 17% share price gain to JP¥27.00, the stock trades at a trailing P/E ratio of 9x. Average trailing P/E is 10x in the Metals and Mining industry in Japan. Total loss to shareholders of 29% over the past three years.
Valuation Update With 7 Day Price Move • Jul 05Investor sentiment improves as stock rises 23%After last week's 23% share price gain to JP¥27.00, the stock trades at a trailing P/E ratio of 9x. Average trailing P/E is 11x in the Metals and Mining industry in Japan. Total loss to shareholders of 27% over the past three years.
お知らせ • Jun 22S Science Company, Ltd. to Report Q1, 2025 Results on Aug 13, 2024S Science Company, Ltd. announced that they will report Q1, 2025 results on Aug 13, 2024
お知らせ • May 31Life Intelligent Enterprise Holdings Co.,Ltd. (TSE:5856) agreed to acquire Nagomi Sekkei Co., Ltd. from S Science Company, Ltd. (TSE:5721).Life Intelligent Enterprise Holdings Co.,Ltd. (TSE:5856) agreed to acquire Nagomi Sekkei Co., Ltd. from S Science Company, Ltd. (TSE:5721) on May 30, 2024. As part of the transaction, Life Intelligent will acquire 3,021 shares of Nagomi Sekkei. The parties are scheduled to enter into an agreement on July 1, 2024 or later after approval at the Shareholders Meeting. The transaction is conditional upon shareholder approval of S Science. The transaction is expected to close on July 1, 2024 or later after approval at the Shareholders Meeting.
分析記事 • May 21Shareholders Shouldn’t Be Too Comfortable With S Science Company's (TSE:5721) Strong EarningsEven though S Science Company, Ltd. ( TSE:5721 ) posted strong earnings recently, the stock hasn't reacted in a large...
Reported Earnings • May 17Full year 2024 earnings released: EPS: JP¥3.01 (vs JP¥0.74 loss in FY 2023)Full year 2024 results: EPS: JP¥3.01 (up from JP¥0.74 loss in FY 2023). Revenue: JP¥1.54b (up 14% from FY 2023). Net income: JP¥426.0m (up JP¥531.0m from FY 2023). Profit margin: 28% (up from net loss in FY 2023). Over the last 3 years on average, earnings per share has increased by 99% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.
お知らせ • May 16S Science Company, Ltd., Annual General Meeting, Jun 27, 2024S Science Company, Ltd., Annual General Meeting, Jun 27, 2024.
分析記事 • Mar 05S Science Company, Ltd.'s (TSE:5721) Share Price Matching Investor OpinionWhen you see that almost half of the companies in the Metals and Mining industry in Japan have price-to-sales ratios...
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improves as stock rises 18%After last week's 18% share price gain to JP¥26.00, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 9x in the Metals and Mining industry in Japan. Total loss to shareholders of 40% over the past three years.
お知らせ • Mar 02S Science Company, Ltd. to Report Fiscal Year 2024 Results on May 13, 2024S Science Company, Ltd. announced that they will report fiscal year 2024 results on May 13, 2024
Reported Earnings • Feb 15Third quarter 2024 earnings released: EPS: JP¥1.04 (vs JP¥0.21 loss in 3Q 2023)Third quarter 2024 results: EPS: JP¥1.04 (up from JP¥0.21 loss in 3Q 2023). Revenue: JP¥339.0m (up 12% from 3Q 2023). Net income: JP¥147.0m (up JP¥177.0m from 3Q 2023). Profit margin: 43% (up from net loss in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings.
お知らせ • Dec 16S Science Company, Ltd. to Report Q3, 2024 Results on Feb 13, 2024S Science Company, Ltd. announced that they will report Q3, 2024 results on Feb 13, 2024
New Risk • Nov 16New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 38% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (38% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Market cap is less than US$100m (JP¥3.12b market cap, or US$20.6m).
Reported Earnings • Nov 12Second quarter 2024 earnings released: EPS: JP¥1.17 (vs JP¥0.064 loss in 2Q 2023)Second quarter 2024 results: EPS: JP¥1.17 (up from JP¥0.064 loss in 2Q 2023). Revenue: JP¥490.0m (up 54% from 2Q 2023). Net income: JP¥166.0m (up JP¥175.0m from 2Q 2023). Profit margin: 34% (up from net loss in 2Q 2023).
お知らせ • Sep 21S Science Company, Ltd. to Report Q2, 2024 Results on Nov 10, 2023S Science Company, Ltd. announced that they will report Q2, 2024 results on Nov 10, 2023
Reported Earnings • Aug 12First quarter 2024 earnings released: EPS: JP¥1.50 (vs JP¥0.22 loss in 1Q 2023)First quarter 2024 results: EPS: JP¥1.50 (up from JP¥0.22 loss in 1Q 2023). Revenue: JP¥446.0m (up 31% from 1Q 2023). Net income: JP¥213.0m (up JP¥244.0m from 1Q 2023). Profit margin: 48% (up from net loss in 1Q 2023).
お知らせ • Jun 22S Science Company, Ltd. to Report Q1, 2024 Results on Aug 10, 2023S Science Company, Ltd. announced that they will report Q1, 2024 results on Aug 10, 2023
Reported Earnings • May 16Full year 2023 earnings released: JP¥0.74 loss per share (vs JP¥2.74 loss in FY 2022)Full year 2023 results: JP¥0.74 loss per share (improved from JP¥2.74 loss in FY 2022). Revenue: JP¥1.36b (up 18% from FY 2022). Net loss: JP¥105.0m (loss narrowed 68% from FY 2022).
お知らせ • May 14S Science Company, Ltd., Annual General Meeting, Jun 29, 2023S Science Company, Ltd., Annual General Meeting, Jun 29, 2023.
Reported Earnings • Feb 15Third quarter 2023 earnings released: JP¥0.21 loss per share (vs JP¥0.73 loss in 3Q 2022)Third quarter 2023 results: JP¥0.21 loss per share (improved from JP¥0.73 loss in 3Q 2022). Revenue: JP¥304.0m (up 1.3% from 3Q 2022). Net loss: JP¥30.0m (loss narrowed 68% from 3Q 2022).
お知らせ • Dec 27S Science Company, Ltd. to Report Q3, 2023 Results on Feb 13, 2023S Science Company, Ltd. announced that they will report Q3, 2023 results on Feb 13, 2023
Reported Earnings • Nov 16Second quarter 2023 earnings released: JP¥0.064 loss per share (vs JP¥0.39 loss in 2Q 2022)Second quarter 2023 results: JP¥0.064 loss per share (improved from JP¥0.39 loss in 2Q 2022). Revenue: JP¥319.0m (up 28% from 2Q 2022). Net loss: JP¥9.00m (loss narrowed 79% from 2Q 2022).
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Outside Independent Director Seiji Arikawa was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 13Second quarter 2023 earnings released: JP¥0.064 loss per share (vs JP¥0.39 loss in 2Q 2022)Second quarter 2023 results: JP¥0.064 loss per share (improved from JP¥0.39 loss in 2Q 2022). Revenue: JP¥319.0m (up 28% from 2Q 2022). Net loss: JP¥9.00m (loss narrowed 79% from 2Q 2022).
お知らせ • Sep 17S Science Company, Ltd. to Report Q2, 2023 Results on Nov 10, 2022S Science Company, Ltd. announced that they will report Q2, 2023 results on Nov 10, 2022
Reported Earnings • Aug 12First quarter 2023 earnings released: JP¥0.22 loss per share (vs JP¥0.77 loss in 1Q 2022)First quarter 2023 results: JP¥0.22 loss per share (up from JP¥0.77 loss in 1Q 2022). Revenue: JP¥340.0m (up 69% from 1Q 2022). Net loss: JP¥31.0m (loss narrowed 62% from 1Q 2022).
お知らせ • Jun 10S Science Company, Ltd. to Report Q1, 2023 Results on Aug 10, 2022S Science Company, Ltd. announced that they will report Q1, 2023 results on Aug 10, 2022
Reported Earnings • May 16Full year 2022 earnings released: JP¥2.74 loss per share (vs JP¥2.67 loss in FY 2021)Full year 2022 results: JP¥2.74 loss per share (down from JP¥2.67 loss in FY 2021). Revenue: JP¥1.16b (up 6.8% from FY 2021). Net loss: JP¥329.0m (loss widened 22% from FY 2021).
お知らせ • May 14S Science Company, Ltd., Annual General Meeting, Jun 29, 2022S Science Company, Ltd., Annual General Meeting, Jun 29, 2022.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Outside Independent Director Seiji Arikawa was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 08S Science Company, Ltd. to Report Fiscal Year 2022 Results on May 12, 2022S Science Company, Ltd. announced that they will report fiscal year 2022 results on May 12, 2022
Reported Earnings • Feb 10Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: JP¥0.73 loss per share (up from JP¥1.12 loss in 3Q 2021). Revenue: JP¥300.0m (up 26% from 3Q 2021). Net loss: JP¥93.0m (loss narrowed 18% from 3Q 2021). Revenue was in line with analyst estimates.
お知らせ • Nov 30S Science Company, Ltd. announced that it has received ¥480 million in funding from LIH Co., Ltd.On November 29, 2021, S Science Company, Ltd closed the transaction.
Reported Earnings • Nov 12Second quarter 2022 earnings released: JP¥0.39 loss per share (vs JP¥1.12 loss in 2Q 2021)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2022 results: Revenue: JP¥250.0m (up 5.0% from 2Q 2021). Net loss: JP¥43.0m (loss narrowed 62% from 2Q 2021).
お知らせ • Mar 13S Science Company, Ltd. to Report Fiscal Year 2021 Results on May 14, 2021S Science Company, Ltd. announced that they will report fiscal year 2021 results on May 14, 2021
お知らせ • Mar 07S Science Company, Ltd. announced that it expects to receive ¥2.75 million in funding from Evolution Capital Management, LLCS Science Co. Ltd. (TSE:5721) announced a third-party allotment agreement for a private placement of 250,000 units of the 6th Stock Acquisition Rights at an issue price of ¥11 per stock acquisition right for gross proceeds of ¥2,750,000 on March 5, 2021. The transaction will involve participation from Evo Fund, a fund managed by Evolution Capital Management, LLC. The stock acquisition right may be converted into 25,000,000 shares (100 shares per stock acquisition right), with initial exercise price of the amount equivalent to 90% of the condition determination standard stock price rounded up to the nearest ¥0.1., and no maximum exercise price. The company will raise ¥1,074,750,000 on exercise of security. The company will pay issuance expenses of ¥8,000,000 and will receive net proceeds on ¥1,074,750,000 on exercise of security. The period during which the stock acquisition rights can be exercised from March 30, 2021 to April 26, 2022. The allotment date is March 29, 2021. The transaction is approved by the board of directors of the company.
Is New 90 Day High Low • Jan 12New 90-day low: JP¥37.00The company is down 20% from its price of JP¥46.00 on 14 October 2020. The Japanese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Metals and Mining industry, which is up 27% over the same period.
お知らせ • Dec 30S Science Company, Ltd. to Report Q3, 2021 Results on Feb 12, 2021S Science Company, Ltd. announced that they will report Q3, 2021 results on Feb 12, 2021
Is New 90 Day High Low • Dec 22New 90-day low: JP¥38.00The company is down 17% from its price of JP¥46.00 on 23 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Metals and Mining industry, which is up 16% over the same period.
Is New 90 Day High Low • Dec 02New 90-day low: JP¥43.00The company is down 4.0% from its price of JP¥45.00 on 03 September 2020. The Japanese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Metals and Mining industry, which is up 10.0% over the same period.
お知らせ • Aug 15S Science Company, Ltd. (TSE:5721) completed the acquisition of Nagomi Sekkei Co., Ltd. from Yasuhiro Fukumura, Kyoko Fukumura, Wakabayashi Tetsuchun, Morita Shinada and others.S Science Company, Ltd. (TSE:5721) concluded a transfer agreement to acquire Nagomi Sekkei Co., Ltd. from Yasuhiro Fukumura, Kyoko Fukumura, Wakabayashi Tetsuchun, Morita Shinada and others for approximately ¥120 million on March 26, 2020. Post completion, Nagomi Sekkei will become wholly owned subsidiary of S Science Company. For the year ended March 31, 2019, Nagomi Sekkei had sales of ¥724 million, operating loss of ¥7 million, net loss of ¥1 million, net assets of ¥19 million and total assets of ¥193 million. Transaction was resolved by the Board of S Science Company. Transaction is expected to close on April 1, 2020. S Science Company, Ltd. (TSE:5721) completed the acquisition of Nagomi Sekkei Co., Ltd. from Yasuhiro Fukumura, Kyoko Fukumura, Wakabayashi Tetsuchun, Morita Shinada and others on April 1, 2020.